tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MLYS Stock Latest News

Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
Pre-EarningsMineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
3d ago
MLYS
Mineralys Therapeutics Advances Lorundrostat Trial Progress
PremiumCompany Announcements
Mineralys Therapeutics Advances Lorundrostat Trial Progress
7d ago
8K
MLYS
Mineralys completes enrollment ahead of schedule in Launch-HTN trial
PremiumThe Fly
Mineralys completes enrollment ahead of schedule in Launch-HTN trial
7d ago
MLYS
Mineralys Therapeutics participates in a conference call with Goldman Sachs
PremiumThe Fly
Mineralys Therapeutics participates in a conference call with Goldman Sachs
13d ago
MLYS
Mineralys Therapeutics to host KOL event on uncontrolled, resistant hypertension
PremiumThe Fly
Mineralys Therapeutics to host KOL event on uncontrolled, resistant hypertension
15d ago
MLYS
Mineralys Therapeutics Hits Enrollment Milestone in Hypertension Trial
PremiumCompany AnnouncementsMineralys Therapeutics Hits Enrollment Milestone in Hypertension Trial
1M ago
8K
MLYS
Mineralys Therapeutics completes target enrollment for Advance-HTN Trial
Premium
The Fly
Mineralys Therapeutics completes target enrollment for Advance-HTN Trial
1M ago
MLYS
Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)
Premium
The Fly
Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)
3M ago
MLYS
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
3M ago
MLYS
Mineralys Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Mineralys Therapeutics initiated with a Buy at H.C. Wainwright
4M ago
MLYS
Mineralys Therapeutics Welcomes Dr. Gold to Board of Directors
PremiumCompany Announcements
Mineralys Therapeutics Welcomes Dr. Gold to Board of Directors
5M ago
8K
MLYS
Mineralys Therapeutics appoints Alexander Gold to board of directors
PremiumThe Fly
Mineralys Therapeutics appoints Alexander Gold to board of directors
5M ago
MLYS
Mineralys Therapeutics CFO Levy sells 96,815 common shares
PremiumThe FlyMineralys Therapeutics CFO Levy sells 96,815 common shares
5M ago
MLYS
3 Best Stocks to Buy Now, 6/12/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 6/12/2024, According to Top Analysts 
5M ago
BRZE
BTDR
Mineralys Therapeutics price target lowered to $26 from $27 at Wells Fargo
Premium
The Fly
Mineralys Therapeutics price target lowered to $26 from $27 at Wells Fargo
6M ago
MLYS
Mineralys Therapeutics reports Q1 EPS (70c), consensus (67c)
PremiumThe Fly
Mineralys Therapeutics reports Q1 EPS (70c), consensus (67c)
6M ago
MLYS
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
7M ago
MLYS
OLMA
Mineralys Therapeutics Board Member Announces Departure
PremiumCompany Announcements
Mineralys Therapeutics Board Member Announces Departure
7M ago
8K
MLYS
Mineralys Therapeutics initiated with a Buy at Goldman Sachs
PremiumThe Fly
Mineralys Therapeutics initiated with a Buy at Goldman Sachs
7M ago
MLYS
Mineralys Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe FlyMineralys Therapeutics initiated with an Outperform at LifeSci Capital
8M ago
MLYS
Mineralys Therapeutics files to sell 8.89M shares of common stock for holders
Premium
The Fly
Mineralys Therapeutics files to sell 8.89M shares of common stock for holders
8M ago
MLYS
Mineralys Therapeutics files $500M mixed securities shelf
Premium
The Fly
Mineralys Therapeutics files $500M mixed securities shelf
8M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >